The UCL Queen Square Institute of Neurology is an institute within the Faculty of Brain Sciences of University College London and is located in London, United Kingdom.

During the past decade, UCL Queen Square Institute of Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCL Queen Square Institute of Neurology" are "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "UCL Queen Square Institute of Neurology" in a lesser frequency.

Most popular intervention types in "UCL Queen Square Institute of Neurology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMX0035" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCL Queen Square Institute of Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCL Queen Square Institute of Neurology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in UCL Queen Square Institute of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCL Queen Square Institute of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".